Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.165 USD | +0.16% | -3.77% | -63.65% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.65% | 330M | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-12.19% | 33.49B | |
-20.59% | 14.62B | |
-9.65% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+4.19% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Piper Sandler Adjusts Revance Therapeutics' Price Target to $42 From $44, Maintains Overweight Rating